🇧🇷 DINUTUXIMAB BETA in Brazil

DINUTUXIMAB BETA (DINUTUXIMAB BETA) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

DINUTUXIMAB BETA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DINUTUXIMAB BETA approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for DINUTUXIMAB BETA in Brazil?

Marketing authorisation holder not available in our data.